{"id":"https://openalex.org/W1997504898","doi":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","title":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa\u2013carbidopa, naltrexone","display_name":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa\u2013carbidopa, naltrexone","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-04","ids":{"openalex":"https://openalex.org/W1997504898","doi":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","mag":"1997504898","pmid":"https://pubmed.ncbi.nlm.nih.gov/24424425","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3944935"},"language":"en","primary_location":{"id":"doi:10.1016/j.drugalcdep.2013.12.015","doi":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997504898"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3944935","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036001319","display_name":"Joy M. Schmitz","orcid":"https://orcid.org/0000-0002-3561-4614","observed_orcids":["https://orcid.org/0000-0002-3561-4614"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Joy M. Schmitz","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States. Electronic address: Joy.M.Schmitz@uth.tmc.edu","Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States. Electronic address: Joy.M.Schmitz@uth.tmc.edu","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079831213","display_name":"Charles E. Green","orcid":"https://orcid.org/0000-0001-9192-8215","observed_orcids":["https://orcid.org/0000-0001-9192-8215"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles E. Green","raw_affiliation_strings":["Center for Clinical Research & Evidence-Based Medicine, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Research & Evidence-Based Medicine, University of Texas, Houston, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071154988","display_name":"Angela L. Stotts","orcid":"https://orcid.org/0000-0002-6042-5276","observed_orcids":["https://orcid.org/0000-0002-6042-5276"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Angela L. Stotts","raw_affiliation_strings":["Department of Family and Community Medicine, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Family and Community Medicine, University of Texas, Houston, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049660486","display_name":"Jan A. Lindsay","orcid":"https://orcid.org/0000-0002-2853-0113","observed_orcids":["https://orcid.org/0000-0002-2853-0113"]},"institutions":[{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210089489","display_name":"Health Services Research & Development","ror":"https://ror.org/0083hz885","country_code":"US","type":"facility","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210089489"]},{"id":"https://openalex.org/I4210119030","display_name":"Mental Illness Research, Education and Clinical Centers","ror":"https://ror.org/02hd1sz82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210119030"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan A. Lindsay","raw_affiliation_strings":["Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, United States; Veterans Affairs South Central Mental Illness Research, Education, and Clinical Center, United States; Houston VA Health Services Research & Development Center of Excellence, United States","Houston VA Health Services Research & Development Center of Excellence, United States","Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, United States","Veterans Affairs South Central Mental Illness Research, Education, and Clinical Center, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, United States; Veterans Affairs South Central Mental Illness Research, Education, and Clinical Center, United States; Houston VA Health Services Research & Development Center of Excellence, United States","institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4210089489"]},{"raw_affiliation_string":"Houston VA Health Services Research & Development Center of Excellence, United States","institution_ids":["https://openalex.org/I4210089489"]},{"raw_affiliation_string":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, United States","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Veterans Affairs South Central Mental Illness Research, Education, and Clinical Center, United States","institution_ids":["https://openalex.org/I1322918889","https://openalex.org/I4210119030"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083104471","display_name":"Nuvan S. Rathnayaka","orcid":"https://orcid.org/0000-0002-9839-9261","observed_orcids":["https://orcid.org/0000-0002-9839-9261"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nuvan S. Rathnayaka","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, University of Texas, Houston, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032888712","display_name":"John G. Grabowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Grabowski","raw_affiliation_strings":["Department of Psychiatry, Medical School, University of Minnesota, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Medical School, University of Minnesota, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045839922","display_name":"Frederick Gerard Moeller","orcid":"https://orcid.org/0000-0003-3683-1407","observed_orcids":["https://orcid.org/0000-0003-3683-1407"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Gerard Moeller","raw_affiliation_strings":["Department of Psychiatry, Virginia Commonwealth University, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Virginia Commonwealth University, United States","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5036001319"],"corresponding_institution_ids":[],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":5.4155,"has_fulltext":false,"cited_by_count":66,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96518894,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"136","issue":null,"first_page":"100","last_page":"107"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.9380000233650208},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.9599999785423279},{"id":"https://openalex.org/keywords/modafinil","display_name":"modafinil","score":0.9150000214576721},{"id":"https://openalex.org/keywords/levodopa-carbidopa","display_name":"levodopa/carbidopa","score":0.9520000219345093},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":1.0},{"id":"https://openalex.org/keywords/contingency-management","display_name":"contingency management","score":0.6869999766349792},{"id":"https://openalex.org/keywords/motivational-interviewing","display_name":"motivational interviewing","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cognitive-behavioral-therapy","display_name":"cognitive behavioral therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.3720000088214874},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.8286283016204834},{"id":"https://openalex.org/C2780714222","wikidata":"https://www.wikidata.org/wiki/Q410441","display_name":"Modafinil","level":2,"score":0.5728548765182495},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.552882969379425},{"id":"https://openalex.org/C105867702","wikidata":"https://www.wikidata.org/wiki/Q5165351","display_name":"Contingency management","level":3,"score":0.5274285078048706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5269095301628113},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5113515257835388},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.4907556474208832},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.45034167170524597},{"id":"https://openalex.org/C2781089641","wikidata":"https://www.wikidata.org/wiki/Q7310684","display_name":"Relapse prevention","level":2,"score":0.4412880539894104},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4364311099052429},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.4222766160964966},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38878393173217773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3276010751724243},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.18837735056877136},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.17322605848312378},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08222237229347229},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077408","descriptor_name":"Modafinil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002230","descriptor_name":"Carbidopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002230","descriptor_name":"Carbidopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015928","descriptor_name":"Cognitive Behavioral Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D039721","descriptor_name":"Diagnostic and Statistical Manual of Mental Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062405","descriptor_name":"Motivational Interviewing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.drugalcdep.2013.12.015","doi":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.drugalcdep.2013.12.015","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},{"id":"pmid:24424425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24424425","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and alcohol dependence","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:europepmc.org:3307374","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3944935","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3944935","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3944935/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Drug Alcohol Depend","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3307374","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3944935","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1620252213","display_name":"Center for Clinical and Translational Sciences (CCTS)","funder_award_id":"UL1TR000371","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5796170645","display_name":"Substance Abuse Research - Medications Development Center","funder_award_id":"P50DA009262","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W136754671","https://openalex.org/W1518897246","https://openalex.org/W1571250981","https://openalex.org/W1580606228","https://openalex.org/W1964510410","https://openalex.org/W1966136869","https://openalex.org/W1973907010","https://openalex.org/W1975271154","https://openalex.org/W1975334732","https://openalex.org/W1979643109","https://openalex.org/W1984667560","https://openalex.org/W1984692505","https://openalex.org/W1986084600","https://openalex.org/W2002793586","https://openalex.org/W2004193818","https://openalex.org/W2007221331","https://openalex.org/W2008541172","https://openalex.org/W2017026105","https://openalex.org/W2020241225","https://openalex.org/W2028455835","https://openalex.org/W2033060965","https://openalex.org/W2037263419","https://openalex.org/W2040832064","https://openalex.org/W2041973032","https://openalex.org/W2043914857","https://openalex.org/W2043955286","https://openalex.org/W2055622849","https://openalex.org/W2058575080","https://openalex.org/W2069296272","https://openalex.org/W2079726518","https://openalex.org/W2080055255","https://openalex.org/W2081120140","https://openalex.org/W2081834159","https://openalex.org/W2082876871","https://openalex.org/W2085381668","https://openalex.org/W2101752617","https://openalex.org/W2102842111","https://openalex.org/W2119274330","https://openalex.org/W2140991283","https://openalex.org/W2145470904","https://openalex.org/W2146598277","https://openalex.org/W2147138162","https://openalex.org/W2157564334","https://openalex.org/W2166790971","https://openalex.org/W2570367220","https://openalex.org/W4233573581"],"related_works":["https://openalex.org/W1965755885","https://openalex.org/W2043955286","https://openalex.org/W1966136869","https://openalex.org/W1965687908","https://openalex.org/W2069296272","https://openalex.org/W2400893210","https://openalex.org/W2105503061","https://openalex.org/W2140991283","https://openalex.org/W1806449367","https://openalex.org/W2072242488"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997504898","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
